Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
40
ELUT Quote, Financials, Valuation and Earnings
Last price:
$0.69
Seasonality move
:
41.01%
Day range:
$0.65 - $0.72
52-week range:
$0.58 - $5.12
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.31x
P/B ratio:
--
Volume:
284.5K
Avg. volume:
223.8K
1-year change:
-86.41%
Market cap:
$27.6M
Revenue:
$24.4M
EPS (TTM):
-$0.92
Analysts' Opinion
-
Consensus RatingElutia, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $4.00, Elutia, Inc. has an estimated upside of 519.68% from its current price of $0.65.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $2.00 representing 100% downside risk from its current price of $0.65.
Fair Value
-
According to the consensus of 2 analysts, Elutia, Inc. has 519.68% upside to fair value with a price target of $4.00 per share.
ELUT vs. S&P 500
-
Over the past 5 trading days, Elutia, Inc. has overperformed the S&P 500 by 4.1% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Elutia, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Elutia, Inc. revenues have been falling on a year-over-year basis for 6 quarters in a row. In the most recent quarter Elutia, Inc. reported revenues of $3.3M.
Earnings Growth
-
Elutia, Inc. has grown year-over-year earnings for 5 quarters straight. In the most recent quarter Elutia, Inc. reported earnings per share of -$0.19.
Enterprise value:
61.4M
EV / Invested capital:
-11.43x
Price / LTM sales:
1.31x
EV / EBIT:
--
EV / Revenue:
2.91x
PEG ratio (5yr expected):
-0.05x
EV / Free cash flow:
-1.84x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$9.7M
Return On Assets:
-61.43%
Net Income Margin (TTM):
-109.03%
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
-131.06%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $25.5M | $22.5M | $21.1M | $3.7M | $3.3M | |
| Gross Profit | $12M | $9.6M | $9.7M | $1.8M | $1.9M | |
| Operating Income | -$21M | -$23.2M | -$21.4M | -$4.5M | -$4.4M | |
| EBITDA | -$17.2M | -$19.7M | -$18M | -$3.6M | -$3.6M | |
| Diluted EPS | -$2.10 | -$2.88 | -$0.92 | -$0.33 | -$0.19 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $39.3M | $43.7M | $39.1M | $37.3M | $18.4M | |
| Total Assets | $59.9M | $61M | $54.6M | $48.4M | $29.4M | |
| Current Liabilities | $22.5M | $40.2M | $44.7M | $39.7M | $41.3M | |
| Total Liabilities | $52M | $71.7M | $84.1M | $88.6M | $73.3M | |
| Total Equity | $7.9M | -$10.7M | -$29.5M | -$40.2M | -$43.9M | |
| Total Debt | $44.1M | $42.4M | $41.8M | $33.3M | $38.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$16.6M | -$20.5M | -$32.3M | -$3.4M | -$2.9M | |
| Cash From Investing | -$463K | $14.2M | -$1.1M | -$547K | -$630K | |
| Cash From Financing | $23.5M | $17.6M | $12.3M | $11.5M | -$262K | |
| Free Cash Flow | -$17.1M | -$21.1M | -$33.4M | -$4M | -$3.5M | |
ELUT
Sector
Market Cap
$27.6M
$28.4M
Price % of 52-Week High
12.61%
50.35%
Dividend Yield
0%
0%
Shareholder Yield
-39.02%
-1.32%
1-Year Price Total Return
-86.41%
-22.19%
Beta (5-Year)
0.630
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$0.63
200-day SMA
Sell
Level
$1.84
Bollinger Bands (100)
Sell
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$0.72
Relative Strength Index (RSI14)
Sell
Level
42.39
ADX Line
Neutral
Level
0
Williams %R
Neutral
Level
-71.2719
50-day SMA
Sell
Level
$0.84
MACD (12, 26)
Sell
Level
-0.08
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-9.8677)
Sell
CA Score
(Annual)
Level (-10.1699)
Buy
Beneish M-Score
(Annual)
Level (-6.9349)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (17.5465)
Sell
Piotroski F Score
(Annual)
Level (3)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (1)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Elutia, Inc. is a biotechnology company, which engages in the provision of biologic products to improve compatibility between medical devices and the patients who need them. It operates through the following segments: Device Protection, Women’s Health, and Cardiovascular. The Device Protection segment includes biological envelope that remodels into systematically connected, vascularized tissue for the long-term pocket protection of certain cardiac and neurostimulator implantable electronic vehicles. The Women’s Health segment includes pre-hydrated, human acellular dermal matrix, or HADM, that is designed to enable rapid integration, cellular repopulation and rapid revascularization at the surgical site. The Cardiovascular segment includes a variety of viable matrices, produced with a proprietary process that is designed to protect and preserve native bone cells and reduce programmable cell death, for use in bone repair and fusion procedures. The Cardiovascular segment includes a portfolio of extracellular matrices that retain the natural composition of collagen, growth factors and proteins for use in vascular and cardiac repair and pericardial closure. The company was founded by Kevin L. Rakin and Charles Randal Mills on August 6, 2015 and is headquartered in Gaithersburg, MD.
Stock Forecast FAQ
In the current month, ELUT has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ELUT average analyst price target in the past 3 months is $4.00.
-
Where Will Elutia, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Elutia, Inc. share price will rise to $4.00 per share over the next 12 months.
-
What Do Analysts Say About Elutia, Inc.?
Analysts are divided on their view about Elutia, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Elutia, Inc. is a Sell and believe this share price will drop from its current level to $2.00.
-
What Is Elutia, Inc.'s Price Target?
The price target for Elutia, Inc. over the next 1-year time period is forecast to be $4.00 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ELUT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Elutia, Inc. is a Buy. 2 of 2 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ELUT?
You can purchase shares of Elutia, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Elutia, Inc. shares.
-
What Is The Elutia, Inc. Share Price Today?
Elutia, Inc. was last trading at $0.69 per share. This represents the most recent stock quote for Elutia, Inc.. Yesterday, Elutia, Inc. closed at $0.65 per share.
-
How To Buy Elutia, Inc. Stock Online?
In order to purchase Elutia, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ELUT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ELUT
Sector
P/E ratio
--
23.66x
PEG ratio
-0.05x
-0.01x
P/B ratio
--
1.84x
Price / LTM sales
1.31x
1.60x
Growth Metrics
ELUT
Sector
Revenue growth
-9.26%
4.85%
Earnings growth
42.31%
11.15%
Revenue (5-year growth)
-10.69%
6.45%
Earnings forecast
--
-$0.20
Profitability
ELUT
Sector
Profitability FY 2024
$10.7M
$3.6M
Return on invested capital
--
-30.98%
Return on assets
-61.43%
-27.62%
Return on equity
--
-36.69%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Mar
5
Estimated Next Earnings Date
Feb
5
Balance Sheet
ELUT
Sector
Total cash
$4.7M
$27.2M
Short term investments
--
$25.7M
Total assets
$36.1M
$79.9M
Long term debt
$38.3M
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
69
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
47
PSTG alert for Dec 4
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
41
SMX alert for Dec 4
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
43
HY alert for Dec 4
Hyster-Yale, Inc. [HY] is up 1.92% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
